Safinamide, a New Anti-Parkinson Agent, is Effective and well-tolerated in Early Parkinson’s Disease PD Patients on a Stable Dose of a Single DA-Agonist: Results of a Randomized, International, Placebo-controlled, Phase III Trial Read more about Safinamide, a New Anti-Parkinson Agent, is Effective and well-tolerated in Early Parkinson’s Disease PD Patients on a Stable Dose of a Single DA-Agonist: Results of a Randomized, International, Placebo-controlled, Phase III Trial
Safinamide - Abstracts from Movement Disorder Society's 11th International Congress, Istanbul Read more about Safinamide - Abstracts from Movement Disorder Society's 11th International Congress, Istanbul
Acquisition of Hunter-Fleming Conference Call Read more about Acquisition of Hunter-Fleming Conference Call
The Nerve Compression and Nerve Entrapment Epidemiology (leaflet) Read more about The Nerve Compression and Nerve Entrapment Epidemiology (leaflet)
